{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:06:15Z","timestamp":1789225575710,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,10]]},"group-title":"Genetic and Genomic Medicine","reference-count":52,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"crossref","award":["Tifft ZIAHG200409"],"award-info":[{"award-number":["Tifft ZIAHG200409"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["Thurm ZICMH002961"],"award-info":[{"award-number":["Thurm ZICMH002961"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Massachusetts Chan School of Medicine"},{"award":["T32GM159591-01"],"award-info":[{"award-number":["T32GM159591-01"]}],"id":[{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01NS114156"],"award-info":[{"award-number":["U01NS114156"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 DK020579"],"award-info":[{"award-number":["P30 DK020579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/02v80fc35","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/01yc7t268","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/00414dg76","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  GM1 gangliosidosis is an inherited and progressively neurodegenerative lysosomal storage disorder with no approved therapy. We report 5-year safety and 3-year clinical, biochemical, and neuroimaging efficacy outcomes following expanded-access intravenous AAV9-GLB1 gene therapy in GT01, a 6-10-year-old female with juvenile-onset GM1 gangliosidosis. During participation in a natural history study before gene transfer, GT01 developed seizures, dysarthria, loss of ambulation, and progressive neurodegeneration. She received a single intravenous administration of AAV9-GLB1 at 1.5\u00d710\n                  <jats:sup>13<\/jats:sup>\n                  vector genomes per kilogram of body weight. Early improvements included the resolution of dysphagia, increased interactions with others, assisted ambulation, and gains in specific domains of adaptive functioning. She was seizure-free without anti-epileptic drugs 18 months post dosing with sustained seizure freedom at the study completion. Cerebrospinal fluid concentrations of GM1 ganglioside and H3N2b (a pentasaccharide biomarker indicative of biochemical improvement in this disorder) concentrations decreased by 50% and \u03b2-galactosidase reached normal activity. Brain, thalamic, and net fiber tract volume assessed by differential tractography increased and ventriculomegaly improved three years post-dosing. These results indicate that meaningful benefit can be achieved even in advanced neurologic disease.\n                <\/jats:p>","DOI":"10.64898\/2026.09.04.26361573","type":"posted-content","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:25:13Z","timestamp":1789089913000},"source":"Crossref","is-referenced-by-count":0,"title":["Expanded Access use of Intravenous Gene Transfer with AAV9-GLB1 in a Juvenile GM1 Gangliosidosis Participant"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-5848","authenticated-orcid":false,"given":"Connor J.","family":"Lewis","sequence":"first","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hera","family":"Akmal","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precilla","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Vezina","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging and Radiology, Children\u2019s National Hospital, Washington D.C., USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selby I.","family":"Chipman","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Blackwood","sequence":"additional","affiliation":[{"name":"Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad H.","family":"Yousef","sequence":"additional","affiliation":[{"name":"Department of Perioperative Medicine, National Institutes of Health Clinical Center, Bethesda MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenaide","family":"Quezado","sequence":"additional","affiliation":[{"name":"Department of Perioperative Medicine, National Institutes of Health Clinical Center, Bethesda MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Powell Gene Therapy Center, University of Florida, Gainesville FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence R.","family":"Flotte","sequence":"additional","affiliation":[{"name":"Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA"},{"name":"Horae Gene Therapy Center and Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Thurm","sequence":"additional","affiliation":[{"name":"Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Gross","sequence":"additional","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-4616","authenticated-orcid":false,"given":"Allison M.","family":"Keeler","sequence":"additional","affiliation":[{"name":"Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[{"name":"Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA"},{"name":"Horae Gene Therapy Center and Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA"},{"name":"Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[{"name":"Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA"},{"name":"Horae Gene Therapy Center and Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Metabolic Disorders, Children\u2019s Hospital of Orange County, Orange, CA, USA"},{"name":"Department of Pediatrics, University of California-Irvine School of Medicine, Orange County, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Acosta","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, MD, USA"},{"name":"Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091207350566000_2026.09.04.26361573v1.1","doi-asserted-by":"crossref","unstructured":"Lewis, C. J. et al. A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis. NeuroSci 6, (2025).","DOI":"10.3390\/neurosci6020031"},{"key":"2026091207350566000_2026.09.04.26361573v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2018.01.002"},{"key":"2026091207350566000_2026.09.04.26361573v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.12.012"},{"key":"2026091207350566000_2026.09.04.26361573v1.4","doi-asserted-by":"crossref","unstructured":"Nicoli, E.-R. et al. GM1 Gangliosidosis-A Mini-Review. Front Genet 12, 734878 (2021).","DOI":"10.3389\/fgene.2021.734878"},{"key":"2026091207350566000_2026.09.04.26361573v1.5","doi-asserted-by":"crossref","unstructured":"D\u2019Souza, P. et al. GM1 gangliosidosis type II: Results of a 10-year prospective study. Genet Med 26, 101144 (2024).","DOI":"10.1016\/j.gim.2024.101144"},{"key":"2026091207350566000_2026.09.04.26361573v1.6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa2510935","article-title":"AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial","volume":"394","year":"2026","journal-title":"N Engl J Med"},{"key":"2026091207350566000_2026.09.04.26361573v1.7","unstructured":"Sparrow, S. S. , Cicchetti, D. V. & Saulnier, C. A. Vineland Adaptive Behavior Scales, Third Edition (Vineland-3). (Pearson, 2016)."},{"key":"2026091207350566000_2026.09.04.26361573v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(93)90067-M"},{"key":"2026091207350566000_2026.09.04.26361573v1.9","doi-asserted-by":"crossref","unstructured":"Kell, P. et al. A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis. EBioMedicine 92, 104627 (2023).","DOI":"10.1016\/j.ebiom.2023.104627"},{"key":"2026091207350566000_2026.09.04.26361573v1.10","first-page":"416","article-title":"Vineland-3 Growth Scale Values: Psychometric Properties for Clinical Trial Readiness in SCN2A","volume":"35","year":"2025","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2026091207350566000_2026.09.04.26361573v1.11","doi-asserted-by":"crossref","unstructured":"Bonnefoy-Mazure, A. , Coulon, G. D. , Lascombes, P. & Armand, S . Follow-up of walking quality after end of growth in 28 children with bilateral cerebral palsy. Journal of Children\u2019s Orthopaedics 14, 41 (2020).","DOI":"10.1302\/1863-2548.14.190125"},{"key":"2026091207350566000_2026.09.04.26361573v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-026-01745-w"},{"key":"2026091207350566000_2026.09.04.26361573v1.13","doi-asserted-by":"crossref","first-page":"fcaf198","DOI":"10.1093\/braincomms\/fcaf198","article-title":"Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases","volume":"7","year":"2025","journal-title":"Brain Commun"},{"key":"2026091207350566000_2026.09.04.26361573v1.14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2019.11.023","article-title":"7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy","volume":"17","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2026091207350566000_2026.09.04.26361573v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab309"},{"key":"2026091207350566000_2026.09.04.26361573v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv168"},{"key":"2026091207350566000_2026.09.04.26361573v1.17","doi-asserted-by":"crossref","unstructured":"Gray-Edwards, H. L. et al. Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model. Molecular Therapy 25, 892 (2017).","DOI":"10.1016\/j.ymthe.2017.01.009"},{"key":"2026091207350566000_2026.09.04.26361573v1.18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007733"},{"key":"2026091207350566000_2026.09.04.26361573v1.19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ymthe.2026.01.004","article-title":"Incidence, timing, and clinical significance of adverse immune events after gene replacement therapy: A systematic review and meta-analysis","volume":"34","year":"2026","journal-title":"Mol Ther"},{"key":"2026091207350566000_2026.09.04.26361573v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00001-6"},{"key":"2026091207350566000_2026.09.04.26361573v1.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307798"},{"key":"2026091207350566000_2026.09.04.26361573v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00313-7"},{"key":"2026091207350566000_2026.09.04.26361573v1.23","doi-asserted-by":"publisher","DOI":"10.1177\/10430342261423168"},{"key":"2026091207350566000_2026.09.04.26361573v1.24","unstructured":"Donald, A. et al. Hemophagocytic Lymphohistiocytosis (Hlh)\/Hyperinflammatory syndrome following high dose Aav9 therapy. American Society of Gene+ Cell Therapy (2025)."},{"key":"2026091207350566000_2026.09.04.26361573v1.25","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/s41591-025-03750-3","article-title":"AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial","volume":"31","year":"2025","journal-title":"Nat Med"},{"key":"2026091207350566000_2026.09.04.26361573v1.26","doi-asserted-by":"crossref","unstructured":"Kolstad, J. et al. Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients. Mol Genet Metab 144, 109025 (2025).","DOI":"10.1016\/j.ymgme.2025.109025"},{"key":"2026091207350566000_2026.09.04.26361573v1.27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ajmg.a.37468","article-title":"MRI\/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis","volume":"170","year":"2016","journal-title":"Am J Med Genet A"},{"key":"2026091207350566000_2026.09.04.26361573v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2017.12.432"},{"key":"2026091207350566000_2026.09.04.26361573v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26558"},{"key":"2026091207350566000_2026.09.04.26361573v1.30","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-026-02315-7"},{"key":"2026091207350566000_2026.09.04.26361573v1.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270325"},{"key":"2026091207350566000_2026.09.04.26361573v1.32","doi-asserted-by":"crossref","unstructured":"Lewis, C. J. et al. Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohorts. Orphanet J Rare Dis 20, 125 (2025).","DOI":"10.1186\/s13023-025-03614-6"},{"key":"2026091207350566000_2026.09.04.26361573v1.33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ajmg.a.63038","article-title":"GM1-gangliosidosis: The caregivers\u2019 assessments of symptom impact and most important symptoms to treat","volume":"191","year":"2023","journal-title":"Am J Med Genet A"},{"key":"2026091207350566000_2026.09.04.26361573v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01664-4"},{"key":"2026091207350566000_2026.09.04.26361573v1.35","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41591-025-03822-4","article-title":"Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1\/2 trial","volume":"31","year":"2025","journal-title":"Nat Med"},{"key":"2026091207350566000_2026.09.04.26361573v1.36","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12646"},{"key":"2026091207350566000_2026.09.04.26361573v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01867-3"},{"key":"2026091207350566000_2026.09.04.26361573v1.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01866-4"},{"key":"2026091207350566000_2026.09.04.26361573v1.39","doi-asserted-by":"crossref","first-page":"e0331275","DOI":"10.1371\/journal.pone.0331275","article-title":"Comparison of neonatal systemic and intracerebroventricular AAV9 gene therapy delivery demonstrating improved behavioral and phenotypic outcomes in a mouse model of Niemann-Pick disease, type C1","volume":"21","year":"2026","journal-title":"PLoS One"},{"key":"2026091207350566000_2026.09.04.26361573v1.40","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1038\/s41591-025-03919-w","article-title":"Oligodendrocyte-targeted adeno-associated virus gene therapy for Canavan disease in children: a phase 1\/2 trial","volume":"31","year":"2025","journal-title":"Nat Med"},{"key":"2026091207350566000_2026.09.04.26361573v1.41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/22143602251324857","article-title":"Quantification and comparison of anti-AAV9 and anti-AAVrh74 antibodies in plasma and human milk: Implications for AAV-based gene therapy candidacy","volume":"12","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"2026091207350566000_2026.09.04.26361573v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2016.03.001"},{"key":"2026091207350566000_2026.09.04.26361573v1.43","doi-asserted-by":"crossref","unstructured":"Manj\u00f3n, J. V. et al. vol2Brain: A New Online Pipeline for Whole Brain MRI Analysis. Front Neuroinform 16, 862805 (2022).","DOI":"10.3389\/fninf.2022.862805"},{"key":"2026091207350566000_2026.09.04.26361573v1.44","doi-asserted-by":"crossref","unstructured":"Tournier, J.-D. et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage 202, 116137 (2019).","DOI":"10.1016\/j.neuroimage.2019.116137"},{"key":"2026091207350566000_2026.09.04.26361573v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2015.10.019"},{"key":"2026091207350566000_2026.09.04.26361573v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2004.07.051"},{"key":"2026091207350566000_2026.09.04.26361573v1.47","unstructured":"Dhollander, T. , Raffelt, D. & Connelly, A. Unsupervised 3-tissue response function estimation from single-shell or multi-shell diffusion MR data without a co-registered T1 image. in ISMRM workshop on breaking the barriers of diffusion MRI vol. 5 1 (Lisbon, 2016)."},{"key":"2026091207350566000_2026.09.04.26361573v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.09.015"},{"key":"2026091207350566000_2026.09.04.26361573v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2008.10.055"},{"key":"2026091207350566000_2026.09.04.26361573v1.50","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2010.2045126"},{"key":"2026091207350566000_2026.09.04.26361573v1.51","doi-asserted-by":"crossref","unstructured":"Yeh, F.-C. et al. Differential tractography as a track-based biomarker for neuronal injury. Neuroimage 202, 116131 (2019).","DOI":"10.1016\/j.neuroimage.2019.116131"},{"key":"2026091207350566000_2026.09.04.26361573v1.52","doi-asserted-by":"crossref","unstructured":"Kell, P. et al. Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. Molecular genetics and metabolism 148, 110159 (2026).","DOI":"10.1016\/j.ymgme.2026.110159"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.04.26361573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:35:20Z","timestamp":1789223720000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.09.04.26361573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":52,"URL":"https:\/\/doi.org\/10.64898\/2026.09.04.26361573","relation":{},"subject":[],"published":{"date-parts":[[2026,9,10]]},"subtype":"preprint"}}